MDLZ:NASDAQMondelez International, Inc. Analysis
Data as of 2026-03-10 - not real-time
$58.17
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Mondelez International trades at $58.17, well above its DCF‑derived fair value of $41.74, implying an overvalued positioning despite a forward P/E of 17.2 versus a trailing P/E of 30.8. The stock yields 3.42% but the payout ratio exceeds 100% (≈102.6%), raising concerns about dividend sustainability. Technical gauges show the price sitting below the 20‑day SMA (60.02) while marginally above the 50‑day SMA (57.94), a neutral trend with a bearish MACD histogram and an RSI of 44.7, suggesting limited upside in the near term.
Revenue grew 9.3% YoY to $38.5 bn, and operating cash flow of $4.5 bn supports the business’s cash‑generating capacity. Analysts remain optimistic, maintaining a Buy consensus and a median price target of $67, indicating a potential 15% upside from current levels. The company’s global brand suite (Oreo, Cadbury, Toblerone) provides defensive exposure, while stable volume and low beta (≈0.09) temper systematic risk. However, 30‑day volatility sits near 26% and the high debt‑to‑equity ratio (≈85%) adds a layer of financial risk.
Revenue grew 9.3% YoY to $38.5 bn, and operating cash flow of $4.5 bn supports the business’s cash‑generating capacity. Analysts remain optimistic, maintaining a Buy consensus and a median price target of $67, indicating a potential 15% upside from current levels. The company’s global brand suite (Oreo, Cadbury, Toblerone) provides defensive exposure, while stable volume and low beta (≈0.09) temper systematic risk. However, 30‑day volatility sits near 26% and the high debt‑to‑equity ratio (≈85%) adds a layer of financial risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below 20‑day SMA indicating limited short‑term momentum
- bearish MACD histogram and neutral RSI
- valuation gap between market price and DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- analyst consensus Buy with median target $67 (~15% upside)
- solid 9.3% revenue growth and strong operating cash flow
- stable volume and low systematic beta supporting price stability
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- global brand portfolio provides defensive resilience
- high dividend payout ratio questions long‑term yield sustainability
- potential for margin improvement as operating efficiency initiatives mature
Key Metrics & Analysis
Financial Health
Revenue Growth9.30%
Profit Margin6.36%
P/E Ratio30.8
ROE9.33%
ROA3.24%
Debt/Equity84.85
P/B Ratio2.9
Op. Cash Flow$4.5B
Free Cash Flow$3.6B
Technical Analysis
TrendNeutral
RSI44.7
Support$57.35
Resistance$62.80
MA 20$60.02
MA 50$57.94
MA 200$61.24
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$41.74
Target Price$66.96
Upside/Downside15.11%
GradeOvervalued
TypeBlend
Dividend Yield3.42%
Risk Assessment
Beta0.09
Volatility25.82%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.